Home › Bronchiolitis Obliterans Syndrome › Alabama
Bronchiolitis Obliterans Syndrome clinical trials in Alabama
3 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- University of Alabama Birmingham, Birmingham
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of Alabama Birmingham, Birmingham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.